117 related articles for article (PubMed ID: 37964466)
21. The USP21 short variant (USP21SV) lacking NES, located mostly in the nucleus in vivo, activates transcription by deubiquitylating ubH2A in vitro.
Okuda H; Ohdan H; Nakayama M; Koseki H; Nakagawa T; Ito T
PLoS One; 2013; 8(11):e79813. PubMed ID: 24278184
[TBL] [Abstract][Full Text] [Related]
22. LncRNA FGD5-AS1 can be predicted as therapeutic target in oral cancer.
Liu L; Zhan Y; Huang Y; Huang L
J Oral Pathol Med; 2020 Mar; 49(3):243-252. PubMed ID: 31899825
[TBL] [Abstract][Full Text] [Related]
23. USP18 contributes to the proliferation and migration of ovarian cancer cells by regulating the AKT/mTOR signaling pathway.
Liu M; Gao S; Xu X; Zhang L; Xu B; Lu D
Acta Biochim Pol; 2022 Jun; 69(2):417-422. PubMed ID: 35696596
[TBL] [Abstract][Full Text] [Related]
24. FOXM1 Deubiquitination by USP21 Regulates Cell Cycle Progression and Paclitaxel Sensitivity in Basal-like Breast Cancer.
Arceci A; Bonacci T; Wang X; Stewart K; Damrauer JS; Hoadley KA; Emanuele MJ
Cell Rep; 2019 Mar; 26(11):3076-3086.e6. PubMed ID: 30865895
[TBL] [Abstract][Full Text] [Related]
25. Lysine demethylase 2A promotes the progression of ovarian cancer by regulating the PI3K pathway and reversing epithelial‑mesenchymal transition.
Lu DH; Yang J; Gao LK; Min J; Tang JM; Hu M; Li Y; Li ST; Chen J; Hong L
Oncol Rep; 2019 Feb; 41(2):917-927. PubMed ID: 30483796
[TBL] [Abstract][Full Text] [Related]
26. Deubiquitinating Enzyme USP21 Inhibits HIV-1 Replication by Downregulating Tat Expression.
Gao W; Li G; Zhao S; Wang H; Huan C; Zheng B; Jiang C; Zhang W
J Virol; 2021 Jun; 95(13):e0046021. PubMed ID: 33827943
[TBL] [Abstract][Full Text] [Related]
27. Non-canonical signaling pathway of SNAI2 induces EMT in ovarian cancer cells by suppressing miR-222-3p transcription and upregulating PDCD10.
Fan L; Lei H; Zhang S; Peng Y; Fu C; Shu G; Yin G
Theranostics; 2020; 10(13):5895-5913. PubMed ID: 32483426
[No Abstract] [Full Text] [Related]
28. 20-hydroxyecdysone suppresses bladder cancer progression via inhibiting USP21: A mechanism associated with deubiquitination and degradation of p65.
Ma Q; Wu F; Liu X; Zhao C; Sun Y; Li Y; Zhang W; Ju H; Wang Y
Transl Oncol; 2024 Jul; 45():101958. PubMed ID: 38663220
[TBL] [Abstract][Full Text] [Related]
29. Down-regulation of PADI2 prevents proliferation and epithelial-mesenchymal transition in ovarian cancer through inhibiting JAK2/STAT3 pathway in vitro and in vivo, alone or in combination with Olaparib.
Liu L; Zhang Z; Zhang G; Wang T; Ma Y; Guo W
J Transl Med; 2020 Sep; 18(1):357. PubMed ID: 32951601
[TBL] [Abstract][Full Text] [Related]
30. ROR2 induces cell apoptosis via activating IRE1α/JNK/CHOP pathway in high-grade serous ovarian carcinoma in vitro and in vivo.
Li R; Liu T; Shi J; Luan W; Wei X; Yu J; Mao H; Liu P
J Transl Med; 2019 Dec; 17(1):428. PubMed ID: 31878941
[TBL] [Abstract][Full Text] [Related]
31. Ablation of USP21 in skeletal muscle promotes oxidative fibre phenotype, inhibiting obesity and type 2 diabetes.
Kim A; Koo JH; Jin X; Kim W; Park SY; Park S; Rhee EP; Choi CS; Kim SG
J Cachexia Sarcopenia Muscle; 2021 Dec; 12(6):1669-1689. PubMed ID: 34523817
[TBL] [Abstract][Full Text] [Related]
32. USP21 deubiquitinase elevates macropinocytosis to enable oncogenic KRAS bypass in pancreatic cancer.
Hou P; Ma X; Yang Z; Zhang Q; Wu CJ; Li J; Tan L; Yao W; Yan L; Zhou X; Kimmelman AC; Lorenzi PL; Zhang J; Jiang S; Spring D; Wang YA; DePinho RA
Genes Dev; 2021 Oct; 35(19-20):1327-1332. PubMed ID: 34531315
[TBL] [Abstract][Full Text] [Related]
33. Ubiquitin specific protease 21 is dispensable for normal development, hematopoiesis and lymphocyte differentiation.
Pannu J; Belle JI; Förster M; Duerr CU; Shen S; Kane L; Harcourt K; Fritz JH; Clare S; Nijnik A
PLoS One; 2015; 10(2):e0117304. PubMed ID: 25680095
[TBL] [Abstract][Full Text] [Related]
34. Down-Regulation of Ubiquitin-Specific Peptidase 9X Inhibited Proliferation, Migration and Invasion of Osteosarcoma via ERK1/2 and PI3K/Akt Signaling Pathways.
Zheng W; Li S; Huang J; Dong Y; Zhang H; Zheng J
Biol Pharm Bull; 2022; 45(9):1283-1290. PubMed ID: 36047196
[TBL] [Abstract][Full Text] [Related]
35. Anticipating resistance to KRAS inhibition: a novel role for USP21 in macropinocytosis regulation.
Crawford HC
Genes Dev; 2021 Oct; 35(19-20):1325-1326. PubMed ID: 34599002
[TBL] [Abstract][Full Text] [Related]
36. Expression of USP7 and MARCH7 Is Correlated with Poor Prognosis in Epithelial Ovarian Cancer.
Zhang L; Wang H; Tian L; Li H
Tohoku J Exp Med; 2016 Jul; 239(3):165-75. PubMed ID: 27302477
[TBL] [Abstract][Full Text] [Related]
37. Downregulation of long noncoding RNA TUSC7 promoted cell growth, invasion and migration through sponging with miR-616-5p/GSK3β pathway in ovarian cancer.
Zhu LM; Li N
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7253-7265. PubMed ID: 32706063
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-145 targets TRIM2 and exerts tumor-suppressing functions in epithelial ovarian cancer.
Chen X; Dong C; Law PT; Chan MT; Su Z; Wang S; Wu WK; Xu H
Gynecol Oncol; 2015 Dec; 139(3):513-9. PubMed ID: 26472353
[TBL] [Abstract][Full Text] [Related]
39. USP21 prevents the generation of T-helper-1-like Treg cells.
Li Y; Lu Y; Wang S; Han Z; Zhu F; Ni Y; Liang R; Zhang Y; Leng Q; Wei G; Shi G; Zhu R; Li D; Wang H; Zheng SG; Xu H; Tsun A; Li B
Nat Commun; 2016 Nov; 7():13559. PubMed ID: 27857073
[TBL] [Abstract][Full Text] [Related]
40. Ubiquitin-specific protease 14 regulates cell proliferation and apoptosis in oral squamous cell carcinoma.
Chen X; Wu J; Chen Y; Ye D; Lei H; Xu H; Yang L; Wu Y; Gu W
Int J Biochem Cell Biol; 2016 Oct; 79():350-359. PubMed ID: 27592452
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
